Dr. Claudio D. Tuda, MD

Dr. Tuda practices at Midway Specialty Care Center Inc in Fort Pierce, Florida.

Dr. Tuda's NPI, 1497728620, was assigned on February 8, 2006. Dr. Tuda graduated from Universidad de Buenos Aires in 1986. Dr. Tuda holds Florida license ME73816.

Dr. Tuda's primary practice is Midway Specialty Care Center Inc, at 356 E Midway Rd, Fort Pierce, FL 34982 in Saint Lucie County. The practice phone is (772) 464-9746.

Dr. Tuda's primary practice is Midway Specialty Care Center Inc in Fort Pierce, Florida. Dr. Tuda is also affiliated with Mount Sinai Medical Center. The medical group on file is Midway Specialty Care Center. Dmand AI also links Dr. Tuda to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tuda practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Tuda's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Tuda is board certified in infectious disease by the American Board of Internal Medicine. Dr. Tuda is licensed in Florida.

CMS data shows 423 Medicare services from Dr. Tuda across 6 procedure codes in 2024, for 192 Medicare patients. Medicare paid $45,051 for them.

CMS counts 192 Medicare patients who saw Dr. Tuda in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 3.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tuda's median patient age at 63, with 28% women.

In 2024, Dr. Tuda wrote 1,319 Medicare Part D claims for 105 patients. 26% of them were for generic drugs. CMS names the drug for 1,122 of them, across 22 drugs with 11 or more claims each, at $3,721,977 in total drug cost. In 2023, CMS named 1,108 claims across 21 drugs.

Dr. Tuda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tuda as offering telehealth.

Dmand AI links 13 papers to Dr. Tuda, published from 2011 to 2023. 2022 was the busiest year, with 3. Dr. Tuda has published most often in Cureus. Dr. Tuda's most frequent co-authors are Nicholas Santiago Camps, DO, Premalkumar M. Patel, MD and Joseph C. Chan, MD.

Dmand AI links Dr. Tuda to 1 clinical trial. 1 is still active or recruiting. Conditions studied include HIV Infections and Lentivirus Infections.

CMS Open Payments shows 1,431 general payments to Dr. Tuda from 32 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 72% of the total. Gilead Sciences, Inc. paid the most, $193,976.

Dr. Tuda graduated from Universidad de Buenos Aires in 1986.

Dr. Tuda is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.